Literature DB >> 2893338

Cardiac alpha-1 adrenoceptors are not involved in heart rate control of the anaesthetized dog.

P Borgdorff1, G Verlato, A Cevese.   

Abstract

To study the possible role of cardiac postsynaptic alpha-1 adrenoceptors in heart rate control of the anaesthetized open-chest dog we injected a specific alpha-1 agonist (amidephrine) into the right coronary artery or stimulated electrically the right stellate ganglion. Reflex influences were minimized by bilateral cervical vagotomy and de-afferentiation of both stellate ganglia. Activation of alpha-2, beta- and muscarinic receptors was prevented by intravenous administration of yohimbine, propranolol and atropine, respectively. Since alpha-1 receptor stimulation could affect heart rate indirectly via coronary constriction, a continuous intracoronary infusion of adenosine (0.25 mg/kg/h) was given. Amidephrine did not affect heart rate at the lower dose (1-10 microgram). After the highest dose (100 micrograms) the maximum variation in heart rate was an increase of 2.2 +/- 1.1 bpm at 3 min after injection (mean +/- SEM; P less than 0.05). This slight cardioacceleration was simultaneous with an aortic pressure rise of 13.8 +/- 3.4 mm Hg and it was abolished by alpha-1 blockade with prazosin (1 mg/kg i.v.). After propranolol (1 mg/kg +0.5 mg/kg/h) the residual positive chronotropic effect of sympathetic stimulation (12.2 +/- 4.0 bpm) was not significantly altered (13.8 +/- 5.7 bpm) by prazosin administration. Similar results were recorded without adenosine infusion. We conclude that in the anaesthetized dog chronotropic effects directly mediated by alpha-1 adrenoceptors either do not exist or lack physiological significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893338     DOI: 10.1007/bf00586531

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  44 in total

1.  AMIDEPHRINE--I: PHARMACOLOGIC CHARACTERIZATION OF A SYMPATHOMIMETIC ALKYLSULFONAMIDOPHENETHANOLAMINE.

Authors:  K W DUNGAN; H C STANTON; P M LISH
Journal:  Int J Neuropharmacol       Date:  1965-07

2.  AMIDEPHRINE--II: CARDIOVASCULAR ACTIONS OF A NEW SYMPATHOMIMETIC AMINE.

Authors:  H C STANTON; K W DUNGAN; P M LISH
Journal:  Int J Neuropharmacol       Date:  1965-07

3.  Frequency-dependence of the positive inotropic effect of methoxamine and naphazoline mediated by alpha-Adrenoceptors in the isolated rabbit papillary muscle.

Authors:  M Endoh; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

4.  Evidence for the existence of alpha adrenergic receptor in isolated rat atria.

Authors:  M Nakashima; Y Hagino
Journal:  Jpn J Pharmacol       Date:  1972-04

5.  Sinus slowing produced by experimental ischemia of the sinus node in dogs.

Authors:  J Billette; V Elharrar; G Porlier; R A Nadeau
Journal:  Am J Cardiol       Date:  1973-03       Impact factor: 2.778

6.  Evidence for adrenergic alpha receptor depressant activity in the heart.

Authors:  T N James; E S Bear; K F Lang; E W Green
Journal:  Am J Physiol       Date:  1968-12

7.  Functional alpha 1-adrenoceptors in the rat heart during beta-receptor blockade.

Authors:  J A Ask; G Stene-Larsen
Journal:  Acta Physiol Scand       Date:  1984-01

8.  Differentiation of cardiac and peripheral alpha- and beta-adrenergic responses to dobutamine, etilefrine and xylometazoline in dogs.

Authors:  R Walkenhorst; D Reinhardt; G Arnold
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

9.  Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations.

Authors:  J Wagner; H J Schümann; A Knorr; N Rohm; J C Reidemeister
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

10.  Intrinsic heart rate in the dog determined by pharmacologic denervation.

Authors:  J R Brunsting; H A Schuil; W G Zijlstra
Journal:  Am J Physiol       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.